Event-related potential changes in groups at increased risk for Alzheimer disease.
BACKGROUND
Individuals who have a family history (FH) of Alzheimer disease (AD) or who carry the apolipoprotein E epsilon4 allele are at increased risk for developing AD. Abnormalities in brain event-related potentials (ERPs) have been observed in patients diagnosed as having AD.


OBJECTIVE
To determine whether groups of nonsymptomatic, middle-aged individuals at increased risk for AD exhibited ERP changes consistent with this disease.


METHODS
In a case-control study, ERPs were elicited using an auditory oddball paradigm, and a brief neuropsychological battery was administered.


METHODS
University laboratory facilities.


METHODS
We compared age-matched and education-matched groups with a positive family history (FH+; n = 24) or a negative family history (FH-; n = 23) of AD. Within the FH+ group, subgroups were identified as either carriers of the apolipoprotein E epsilon4 allele (epsilon4+; n = 9) or noncarriers (epsilon4-; n = 8), and these subgroups were compared with the FH- group.


METHODS
The latency and amplitudes of P3, N2, and P2 components of the ERP were quantified and analyzed statistically.


RESULTS
Compared with the FH- group, both the whole FH+ group and the FH+/epsilon4+ subgroup showed abnormal prolongation in the latency of the P3 component. In addition, the FH+/epsilon4+ subgroup showed abnormal prolongation in the latency of the N2 component. These changes were observed in the absence of neuropsychological deficits.


CONCLUSIONS
The findings indicate that groups at increased risk for developing AD show ERP changes consistent with those observed in patients diagnosed as having AD. The results support accumulating evidence that AD has a preclinical phase and that early detection may be possible.
Green
J
J
Department of Neurology, Emory University, School of Medicine, Wesley Woods Center, Atlanta, GA 30329, USA. jgreen@emory.edu
Levey
A I
AI
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology*; D001057:Apolipoproteins E / Q000235:genetics; D001921:Brain / Q000503:physiopathology*; D016022:Case-Control Studies; D005071:Evoked Potentials / Q000502:physiology*; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D009483:Neuropsychological Tests; D018570:Risk Assessment; D012307:Risk Factors
D001057:Apolipoproteins E